Oscar Health, Inc. (OSCR) FY2026 Q2 P&L / Income Statement

Oscar Health, Inc. (OSCR) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

4,880,220,000 US dollars

Total operating expenses

4,491,585,000 US dollars

Earnings (loss) from operations

388,635,000 US dollars

Other income (expense), net (calculated)

negative 5,624,000 US dollars

Earnings (loss) before income taxes

383,011,000 US dollars

Income tax expense (benefit)

21,183,000 US dollars

Net income (loss)

361,828,000 US dollars

Premium

4,789,331,000 US dollars

Investment income

84,794,000 US dollars

Other revenues

6,095,000 US dollars

Medical

3,794,445,000 US dollars

Depreciation and amortization

6,060,000 US dollars

Selling, general, and administrative

691,080,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Oscar Health, Inc.: $361.81 M; to noncontrolling interests: $20.00 K.